Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPH Group (T) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 152.47 | 115.35 | 85.14 | 71.22 | 42.47 |
| Expenses | |||||
| Material consumed | 88.02 | 63.64 | 40.89 | 37.92 | 20.41 |
| Manufacturing expenses | 18.88 | 12.95 | 10.40 | 7.54 | 6.61 |
| Personnel expenses | 19.03 | 15.87 | 14.50 | 11.98 | 10.25 |
| Selling expenses | 0.47 | - | 0.14 | 0.01 | 0.01 |
| Adminstrative expenses | 14.95 | 7.17 | 7.71 | 3.47 | 3.96 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 141.35 | 99.63 | 73.65 | 60.92 | 41.24 |
| Operating profit | 11.11 | 15.72 | 11.49 | 10.30 | 1.23 |
| Other recurring income | 3.52 | 3.27 | 2.10 | 0.75 | 0.26 |
| Adjusted PBDIT | 14.63 | 18.99 | 13.59 | 11.05 | 1.48 |
| Financial expenses | 2.29 | 2.04 | 0.79 | 0.74 | 0.10 |
| Depreciation | 5.00 | 5.33 | 5.49 | 4.48 | 3.27 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 7.35 | 11.62 | 7.31 | 5.83 | -1.88 |
| Tax charges | - | 0.28 | - | - | - |
| Adjusted PAT | - | 11.34 | - | - | - |
| Non recurring items | 0.04 | 0.15 | -2.16 | - | -23.33 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 7.38 | 11.49 | 5.15 | 5.83 | -25.20 |
| Earnigs before appropriation | -47.10 | -54.48 | -66.01 | -71.17 | -76.99 |
| Equity dividend | - | - | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | -47.10 | -54.48 | -66.01 | -71.17 | -76.99 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis